Prostate cancer affects 1 in 6 men in the USA. Every man over the age of 45 is at risk for prostate cancer. Systematic transrectal ultrasound (TRUS)-guided biopsy is the standard method for a definitive diagnosis of prostate cancer. More than 1.2 million prostate biopsies are performed annually and the medical cost is more than two billion dollars each year. However, this technique has a significant sampling error and is characterized by low sensitivity (39-52%). This "blind" biopsy approach can miss 30% of prostate cancers. As a negative biopsy does not preclude the possibility of a missed cancer, both the physicians and patients face challenges in making treatment decisions. Due to the increasing number of younger men with potentially early and curable prostate cancer, this problem must be addressed in order to improve cancer detection rate. At our NIH/NCI-supported Emory Molecular and Translational Imaging Center, positron emission tomography (PET) with a new molecular imaging tracer FACBC has shown very promising results for prostate cancer detection in human patients. We hypothesize that FACBC PET molecular images can be incorporated into ultrasound-guided biopsy for improved cancer detection. The proposed research is to develop a molecular image-directed, 3D ultrasound-guided system for targeted biopsy of the prostate.
Specific Aim 1 : To modify a real-time, mechanically assisted, 3D ultrasound-guided device. Compared to conventional 2D image guidance, 3D images of the prostate will be used to guide the biopsy.
Specific Aim 2 : To develop fast deformable and statistical appearance model based segmentation methods for 3D ultrasound images of the prostate. Statistical shape models will be developed from our database and will be used to guide automatic segmentation of the prostate.
Specific Aim 3 : To combine FACBC molecular images with 3D ultrasound for targeted biopsy. New deformable image registration methods based joint saliency map and fuzzy point correspondence will be developed in order to solve major limitations of mutual information based image registration.
Specific Aim 4 : To test the accuracy of the integrated biopsy system in phantoms and animals. The complete biopsy system will also be tested in a small number of human patients. Our FACBC patient studies are supported by the NIH-sponsored imaging center program (P50CA128301) and by the Phase II Clinical Trial (NCT00562315). The mechanically assisted device has received the FDA 510K approval. The proposed study will promote the academic-industrial collaboration (Emory University, Robarts Research Institute of the University of Western Ontario, and Eigen Inc., Grass Valley, CA). If completely developed, the multimodality molecular image-guided system will be able to be used not only for biopsy but also for brachytherapy, radiofrequency thermal ablation, cryotherapy, and photodynamic therapy.

Public Health Relevance

The research could improve prostate cancer detection by using novel molecular imaging technology and by using a new three-dimensional image-guided biopsy device. The molecular image-guided system can be used not only for improved biopsy of diseases but also for minimally invasive therapy of cancers.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Biomedical Imaging Technology Study Section (BMIT)
Program Officer
Tandon, Pushpa
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Emory University
Schools of Medicine
United States
Zip Code
Lu, Guolan; Halig, Luma; Wang, Dongsheng et al. (2014) Spectral-Spatial Classification Using Tensor Modeling for Cancer Detection with Hyperspectral Imaging. Proc SPIE Int Soc Opt Eng 9034:903413
Lu, Guolan; Halig, Luma; Wang, Dongsheng et al. (2014) Hyperspectral Imaging for Cancer Surgical Margin Delineation: Registration of Hyperspectral and Histological Images. Proc SPIE Int Soc Opt Eng 9036:90360S
Qin, Xulei; Wang, Silun; Shen, Ming et al. (2014) Mapping Cardiac Fiber Orientations from High-Resolution DTI to High-Frequency 3D Ultrasound. Proc SPIE Int Soc Opt Eng 9036:90361O
Pike, Robert; Patton, Samuel K; Lu, Guolan et al. (2014) A Minimum Spanning Forest Based Hyperspectral Image Classification Method for Cancerous Tissue Detection. Proc SPIE Int Soc Opt Eng 9034:90341W
Lu, Guolan; Halig, Luma; Wang, Dongsheng et al. (2014) Spectral-spatial classification for noninvasive cancer detection using hyperspectral imaging. J Biomed Opt 19:106004
Qin, Xulei; Lu, Guolan; Sechopoulos, Ioannis et al. (2014) Breast Tissue Classification in Digital Tomosynthesis Images Based on Global Gradient Minimization and Texture Features. Proc SPIE Int Soc Opt Eng 9034:90341V
Qin, Xulei; Fei, Baowei (2014) Measuring myofiber orientations from high-frequency ultrasound images using multiscale decompositions. Phys Med Biol 59:3907-24
Wang, Dongsheng; Fei, Baowei; Halig, Luma V et al. (2014) Targeted iron-oxide nanoparticle for photodynamic therapy and imaging of head and neck cancer. ACS Nano 8:6620-32
Malliori, A; Bliznakova, K; Sechopoulos, I et al. (2014) Breast tomosynthesis with monochromatic beams: a feasibility study using Monte Carlo simulations. Phys Med Biol 59:4681-96
Yang, Xiaofeng; Fei, Baowei (2013) Multiscale segmentation of the skull in MR images for MRI-based attenuation correction of combined MR/PET. J Am Med Inform Assoc 20:1037-45

Showing the most recent 10 out of 21 publications